Gesamtlänge aller Episoden: 14 days 8 hours 1 minute
Join us as we learn more about the new Hevylite® test for myeloma patients - when it should be used and why it is important with Dr. Stephen Harding of The Bind
Join us as we learn more about the new Hevylite® test for myeloma patients - when it should be used and why it is important with Dr. Stephen Harding of The Bind
Join us as we talk with Dr. Saad Usmani, MD about his new position as Director of Clinical Research for Hematologic Malignancies and Director of Plasma Cell Dis
Join us as we talk with Dr. Saad Usmani, MD about his new position as Director of Clinical Research for Hematologic Malignancies and Director of Plasma Cell Dis
Clinical trials for high-risk myeloma patients.
Hear from Dr. Brendan Weiss, MD from the Abramson Cancer Center at the University of Pennsylvania about the indicators and factors that can MGUS progression to
Hear from Dr. Brendan Weiss, MD from the Abramson Cancer Center at the University of Pennsylvania about the indicators and factors that can MGUS progression to
What affects myeloma progression?
Join us as we talk in detail about the recent announcement by the Mayo Clinic on Dr. Stephen Russell, MD, PhD's success in using the measles vaccine to halt mye
Join us as we talk in detail about the recent announcement by the Mayo Clinic on Dr. Stephen Russell, MD, PhD's success in using the measles vaccine to halt mye